Inside the research
Hims & Hers Health, Inc.
HIMS Research profile · latest available data
Price overview
$29.42
▲ +0.14 (+0.5%)
| 52w hi | $62.76 |
|---|---|
| 52w lo | $14.52 |
| Vol | 8.19M |
| As of | 25 Sep 2026 |
The Verdict
Our score -0.36
| Short | -0.32 |
|---|---|
| Medium | -0.30 |
| Long | -0.53 |
computed 2026-09-27
Key fundamentals
Hims & Hers Health, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
| Market cap | $6.86B |
|---|---|
| Enterprise value | $7.57B |
| Forward P/E | 39.90x |
| EV / EBITDA | -743.76x |
| P / S (ttm) | 2.66x |
| Profit margin | -5.5% |
| Return on equity | -32.0% |
| Revenue growth | +38.2% |
| Debt / equity | 477.13 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | -0.04 | |
| Sector | +0.08 | |
| Technical | -0.27 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.
Risk Metrics
| Beta vs SPX | 2.53 |
|---|---|
| Corr SPX | 0.39 |
| Annual vol | 104.0% |
| Annual ret | +83.6% |
| Sharpe | 0.80 |
| Max DD | -78.9% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-10 | Earnings Release, Exhibits | read |
| 2026-07-17 | Officer / Director Change | read |
| 2026-07-01 | Material Agreement, Material Obligation… | read |
| 2026-06-15 | Shareholder Vote | read |
| 2026-06-02 | Material Agreement, Material Obligation… | read |
| 2026-05-21 | Material Agreement, Material Obligation… | read |
| 2026-05-19 | Other Material Event, Exhibits | read |
| 2026-05-11 | Earnings Release, Exhibits | read |
| 2026-03-11 | Reg FD Disclosure, Exhibits | read |
| 2026-02-23 | Earnings Release, Exhibits | read |
| 2026-02-19 | Material Agreement, Securities Issuance… | read |
| 2025-11-17 | Other Material Event | read |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 8 |
| Top-5 share | 99.2% |
| HHI | 2,814 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| Citadel Advisors | $348.06M | 10.04M |
| State Street Corp | $282.41M | 8.15M |
| Fidelity / FMR LLC | $149.89M | 4.32M |
| Capital Research / Capital World | $101.22M | 2.92M |
| Millennium Management | $23.22M | 669.60K |
| AQR Capital Management | $7.07M | 210.08K |
| Bridgewater Associates | $243.94K | 7.04K |
| T. Rowe Price Group | $32.32K | 932.22K |
As of 2026-06-30
SEC Filings
The Long Run
FY 2019–2025 · 7 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $2.35B | +71.4% | |
| Gross profit | $1.73B | +70.6% | |
| Operating income | $105.61M | — | |
| Net income | $128.37M | +11088.8% | |
| Cash from ops | $73.48M | +0.0% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $29.48 | $29.76 | $28.57 | $29.42 | 8.19M |
| Sep 24 | $28.00 | $29.65 | $27.31 | $29.28 | 16.71M |
| Sep 23 | $30.40 | $30.95 | $28.32 | $28.39 | 11.89M |
| Sep 22 | $29.95 | $31.81 | $29.22 | $30.43 | 16.65M |
| Sep 21 | $28.50 | $29.52 | $28.18 | $29.35 | 8.45M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →